Lv1
60 积分 2025-08-26 加入
Additive Effekte durch die Kombination von Finerenon und Empagliflozin bei chronischer Nierenerkrankung und Typ-2-Diabetes? – Ergebnisse des CONFIDENCE Trials
2个月前
已关闭
The effect of Empagliflozin on alleviating C4d over-activation in Diabetic kidney disease
2个月前
已关闭
Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial
2个月前
已完结
Effect of ipragliflozin on endothelial dysfunction in patients with type 2 diabetes and chronic kidney disease: A randomized clinical trial (PROCEED)
2个月前
已关闭
Effects of Dapagliflozin on Health-Related Quality of Life in Patients with CKD
3个月前
已完结
Benefit-Risk Profile of P2X3 Receptor Antagonists for Treatment of Chronic Cough: Dose-Response Model-Based Network Meta-Analysis
8个月前
已完结
Improving Empiric Antibiotic Selection for Patients Hospitalized With Abdominal Infection: The INSPIRE 4 Cluster Randomized Clinical Trial
8个月前
已完结
Efficacy and safety of janagliflozin as add-on therapy to metformin in Chinese patients with type 2 diabetes inadequately controlled with metformin alone: A multicentre, randomized, double-blind, placebo-controlled, phase 3 trial
11个月前
已完结
Effects of dapagliflozin on postprandial lipid metabolism in type 2 diabetes mellitus
11个月前
已完结
Effects of empagliflozin on estimated extracellular volume, estimated plasma volume, and measured glomerular filtration rate in patients with heart failure (Empire HF Renal): a prespecified substudy of a double-blind, randomised, placebo-controlled trial
11个月前
已完结
皖公网安备34019202002308
